BIOTECHNOLOGY VALUE FUND L P

Holdings History for Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

Symbol: CGEM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,918,481 shares
Security Ownership %: 10%

BVF PARTNERS L P/IL ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)

17 Feb 2026 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,918,481 shares of Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM). This represents 10% ownership of the company. This is the first filing by BIOTECHNOLOGY VALUE FUND L P disclosing ownership of Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	10%		$64,748,182	5,918,481			$10.94	13G/A	31 Dec 2025	17 Feb 2026, 16:10